First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 47 (7), 1274-1282
- https://doi.org/10.1080/10428190600562823
Abstract
Although most patients diagnosed with extranodal NK/T-cell lymphoma (NTCL) have localized disease, radiotherapy alone is unsatisfactory because of frequent systemic failure and conventional doxorubicin-based chemotherapy has low efficacy. Twenty-six patients with NTCL received ifosfamide, methotrexate, etoposide and prednisolone (IMEP) chemotherapy as first-line treatment [ifosfamide 1.5 g/m2 (days 1 – 3), methotrexate 30 mg/m2 (days 3 and 10), etoposide 100 mg/m2 (days 1 – 3) and prednisolone 120 mg (days 1 – 5)]. Radiotherapy was administered only to patients with Ann Arbor stage I/II that had not achieved complete remission (CR) or to those that developed local failure after completing chemotherapy. Sixteen patients (group A) had nasal or upper aerodigestive tract localization (stage I/II) and 10 (group B) had extranasal or disseminated disease. Of the 14 evaluable patients in group A, 11 (79%) achieved CR after IMEP alone and 13 (93%) after chemotherapy ± additional radiotherapy. Although, out of the 11 patients who achieved CR with chemotherapy alone, seven developed recurrence, all recurrences were local failure and successfully treated by additional curative radiotherapy. However, patients in group B responded poorly (CR 13%). IMEP regimen was active in NTCL patients with nasal or upper aerodigestive tract localization. Considering local failure rate after IMEP alone, initial IMEP chemotherapy followed by radiotherapy may be a promising treatment strategy in this subset of NTCL.Keywords
This publication has 22 references indexed in Scilit:
- Radiation therapy versus chemotherapy as initial treatmentfor localized nasal natural killer (NK)/T-cell lymphoma:a single institute survey in TaiwanAnnals of Oncology, 2004
- Therapeutic Outcome of Extranodal NK/T-Cell Lymphoma Initially Treated with Chemotherapy Result of Chemotherapy in NK/T-Cell LymphomaActa Oncologica, 2003
- Nasal NK/T-Cell Lymphoma with Disseminated Disease Treated with Aggressive Combined TherapyMedical Oncology, 2003
- Lymphoma of the nasal cavity and paranasal sinusesCancer, 1997
- Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.Radiology, 1997
- Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year periodRadiotherapy and Oncology, 1996
- Radiotherapy Compared to Chemotherapy as Initial Treatment of Angiocentric Centrofacial Lymphoma (Polymorphic Reticulosis)Acta Oncologica, 1993
- The protean clinical features of polymorphic reticulosis (lethal midline granuloma)The Laryngoscope, 1976
- Midline Malignant Reticulosis: A Clinicopathologic EntityJAMA Otolaryngology–Head & Neck Surgery, 1972
- Primary lymphoma of the nose including a relationship to lethal midline granulomaThe American Journal of Surgery, 1966